<PRE>
[Federal Register: March 23, 2001 (Volume 66, Number 57)]
[Notices]               
[Page 16252]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr23mr01-91]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

 
Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory 
Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.

     Name of Committee: Pediatric Oncology Subcommittee of the 
Oncologic Drugs Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on April 24, 2001, 8 
a.m. to 4 p.m.
    Location: Best Western Washington Gateway Hotel, The Ballroom, 
1251 West Montgomery Ave., Rockville, MD.
    Contact: Karen M. Templeton-Somers, Center for Drug Evaluation 
and Research (HFD-21), Food and Drug Administration, 5600 Fishers 
Lane, Rockville, MD 20857, 301-827-7001, e-mail: at 
<A HREF="mailto:SomersK@cder.fda.gov">SomersK@cder.fda.gov</A>, or FDA Advisory Committee Information Line, 1-
800-741-8138 (301-443-0572 in the Washington, DC area), code 12542. 
Please call the Information Line for up-to-date information on this 
meeting.
    Agenda: The subcommittee will discuss parameters used for 
extrapolation from the adult to the pediatric setting in the 
hematological malignancies of leukemia and lymphoma.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the 
subcommittee. Written submissions may be made to the contact person 
by April 17, 2001. Oral presentations from the public will be 
scheduled between approximately 8:15 a.m. and 8:45 a.m., and 1 p.m. 
and 1:30 p.m. Time allotted for each presentation may be limited. 
Those desiring to make formal oral presentations should notify the 
contact person before April 17, 2001, and submit a brief statement 
of the general nature of the evidence or arguments they wish to 
present, the names and addresses of proposed participants, and an 
indication of the approximate time requested to make their 
presentation.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: March 16, 2001.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 01-7185 Filed 3-22-01; 8:45 am]
BILLING CODE 4160-01-S

</PRE>